Page 94 - Contract Development News Today

Search jobs 11-May-2021 RoslinCT has been selected as the second National Training Centre in the Advanced Therapies Skills Training Network RoslinCT has been selected as the second National Training Centre in the Advanced Therapies Skills Training Network RoslinCT will collaborate with the Scottish Universities Life Sciences Alliance (SULSA) and additional academic institutions to deliver high impact advanced therapy and vaccine manufacturing GMP t...

Eurofins Scientific: Eurofins Successfully Prices New EUR 750m 10-year 0.875%-coupon Senior Unsecured Bonds Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3 by Moodys and BBB- by Fitch, " Eurofins"), a global leader in bioanalytical testing, announces that it has successfully raised EUR 750m in its latest senior unsecured Euro bond public issuance (the " Bonds"). These Bonds are the first ones issued by Eurofins since it received an investment grade credit rating by Moodys and Fitch rating ...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3 by Moody’s and BBB- by Fitch, “ Eurofins”), a global leader in bioanalytical testing, announces that it has successfully raised EUR 750m in its latest senior unsecured Euro bond public issuance (the “ Bonds”). These Bonds are the first ones issued by Eurofins since it received an investment grade credit rating by Moody’s and Fitch rating agencies. The Bonds have a 10-year maturity (due...

Search jobs 10-May-2021 Eurofins Announces Its Intention to Issue New Euro Bonds of Benchmark Size to Refinance Part of Its Existing Bonds LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3 by Moody’s and BBB- by Fitch, “ Eurofins”), a global leader in bioanalytical testing, announces today: its intention to issue new Euro-denominated bonds for a benchmark size (between EUR 500M and EUR 750M) (the...

WuXi Biologics Completed Three Acquisitions to Enhance its Global Network SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal, Germany, the Pfizer China ("Pfizer") manufacturing facilities in Hangzhou, China as well as CMAB Biopharma Group ("CMAB"). Under the acquisition agreement signed in December 202...

07 maggio 2021 09:02 Fonte: Adnkronos #chimica-e-farmacia SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal, Germany, the Pfizer China ("Pfizer") manufacturing facilities in Hangzhou, China as well as CMAB Biopharma Group ("CMAB"). Under the acquisition agreement signed in December 2020 with Bayer, ...

Eurofins Scientific: Eurofins Announces Its Investment Grade Credit Rating Assigned by Fitch Regulatory News: Eurofins Scientific (Paris:ERF) (EUFI.PA), a global leader in bioanalytical testing, announces today that it has received a public long-term issuer credit rating by Fitch Ratings (" Fitch") which assigned an investment grade rating of BBB- with a stable outlook. This second credit rating equivalent to its inaugural credit rating of Baa3 (stable) assigned by Moodys in July 2020, confirm...

Oculis Selects AGC Biologics Heidelberg Facility to Manufacture OCS-02 Seattle, May 06, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with Oculis to manufacture OCS-02, a Phase II investigational drug targeting both Dry Eye Disease and Anterior Uveitis, at its Heidelberg facility. "We are very pleased that Oculis has chosen us to manufacture this treatment," says AGC Biologics ...

PORTSMOUTH -- Lonza Biologics intends to add 32,300 square feet of additional manufacturing space and 250 new jobs to its plant at the Pease International Tradeport. The company Thursday morning announced expansion plans for both the Portsmouth facility and its plant in Visp, Switzerland, in response to what it said is a growth in the biologics market, particularly as the world has focused attention on a COVID-19 vaccine that Lonza is producing in concert with Moderna. This expansion is plann...

German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand HAMBURG, Germany, May 06, 2021 / B3C newswire / --Richter-Helm BioLogics GmbH & Co. KG, a leading Germany-based, cGMP compliant biopharmaceutical Contract Development and Manufacturing Organization (CDMO) announced today the start of construction for an expansion project at its cGMP manufacturing facility in Bovenau, Germany. The new multi-product biological manufacturing facility is expected to begin ...